Try our Advanced Search for more refined results

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. February 15, 2023

    'Egregious' Opioid Sales Support $650M Verdict, 6th Circ. Told

    The Ohio counties of Lake and Trumbull late Tuesday defended their milestone $650 million opioid trial win over pharmacy giants CVS, Walgreens and Walmart, telling the Sixth Circuit that their claims that the pharmacies created a public nuisance by "egregious" opioid dispensing aren't barred by federal law.

  2. February 14, 2023

    Opioids More Addictive Than Cocaine, Ga. Jury Told

    Prescription opioids are more addictive than cocaine, a recovering addict told a Georgia jury Tuesday during the third week of a trial against drug distribution giants accused of bombarding a Peach State community with pills for profit.

  3. February 10, 2023

    Opioid Judge Targets 'Unfortunate' Gaps In Pharmacy Deals

    The federal judge overseeing nationwide opioid litigation refused Friday to delay business practice changes at CVS, Walgreens and Walmart locations in two Ohio counties, pressuring the pharmacies to adopt the changes in nationwide settlements and rectify "unfortunate" omissions.

  4. February 06, 2023

    Bank Botched Artist Benton's Trust By $400M, Judge Hears

    Missouri bank UMB "egregiously" mismanaged the collection of prominent 20th-century painter Thomas Hart Benton through four decades of sweetheart sales to executives, art museums and bank customers, and failed to care for and monetize his intellectual property, a judge heard as trial started Monday.

  5. February 03, 2023

    Opioids Ravaged Ga. Family, Jury Told In Distributor Case

    A Georgia fire captain took the stand Friday as the first plaintiff to testify in a private opioid trial against major drug distributors, telling jurors the drugs exacted a heavy toll on his relatives and their relationships.

  6. January 31, 2023

    DEA Faulted Controls At Opioid Distributors, Ga. Jury Hears

    A Georgia jury weighing claims that major drug distributors fueled addiction heard Tuesday from a former U.S. Drug Enforcement Administration agent who testified that the regulator repeatedly investigated Cardinal Health and McKesson warehouses nationwide and found the distributors weren't properly controlling dangerous drugs.

  7. January 30, 2023

    Opioid Victim Families Go To Trial Against Distributors In Ga.

    Nearly two dozen Georgians went to trial Monday against opioid distributors over claims the companies share blame for their family members' addictions, previewing some of the most personal stories told thus far in nationwide opioid litigation.

  8. January 17, 2023

    Mich. County Loses Challenge To $800M Opioid Payout Plan

    Michigan's first wave of funds from a national settlement with opioid distributors and manufacturers can start to flow to local governments after a federal court dismissed one county's challenge to how the funds were apportioned.

  9. January 03, 2023

    Health & Pharma Legal Clashes Didn't Take A Holiday Break

    While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.

  10. January 02, 2023

    Health Care & Life Sciences Litigation To Watch In 2023

    Before the New Year's Eve confetti has even been swept up, lawyers specializing in health care and life sciences already have enough litigation to keep them busy for much of 2023, which is kicking off with federal courts eyeing suits that carry sweeping significance for administrative law, the False Claims Act, drug approvals, the opioid crisis and abortion rights.